For patients with DMD caused by a deletion of exons 38–45 of the DMD gene, pathogenetic and etiotropic therapy is unavailable; however, corticosteroids are proven to be effective in patients with this type of muscular dystrophy [3] as a supportive therapy during the wait for new genotherapeutic medication for this disorder [4]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.